Bookmark

Add to MyYahoo RSS

Zetia, Ezetimibe News

News on Zetia, Ezetimibe (generic) continually updated from thousands of sources around the net.

Sunday Aug 24 | Sys-Con Media

Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab...

Top-line results from nine ODYSSEY Phase 3 trials were announced in late ODYSSEY LONG-TERM - The 2,341-patient, double-blind trial is evaluating the long-term safety and efficacy of alirocumab versus placebo in combination with maximally tolerated lipid-lowering therapy, including statins, in patients with hypercholesterolemia who are at high ... (more)

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Healthcare Law, Law

Tue Aug 12, 2014

Forbes.com

IMPROVE-IT Trial Scheduled For Presentation In November

Results of the eagerly-awaited and highly controversial IMPROVE-IT trial are finally going to be revealed.

Comment?

Related Topix: Healthcare Law, Law, Zocor, Simvastatin (generic), Medicine, Business News

Fri Aug 01, 2014

Medical News Today

Sanofi and Regeneron report positive top-line results from nine phase ...

Sanofi and Regeneron Pharmaceuticals, Inc. have announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared to placebo or active comparator.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Cholesterol, Health, Lipitor, Atorvastatin (generic)

Wed Jul 30, 2014

P&T Community

Positive Results Reported From Nine Phase III Trials of Alirocumab in Hypercholesterolemia

Nine new phase III studies of alirocumab in patients with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared with placebo or an active comparator.

Comment?

Related Topix: Medicine, Cholesterol, Health, Angina, Lipitor, Atorvastatin (generic)

Tue Jul 29, 2014

Brandon Sun

Merck second-quarter profit more than doubles, tops forecast

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Whitehouse Station, NJ

•••
•••
•••
•••
•••
•••
•••